Orally Delivered, Plant-Produced Tat Protein Primes Mice For a Challenge DNA Vaccine Expressing Tat by unknown
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessOral presentation
Orally Delivered, Plant-Produced Tat Protein Primes Mice For a 
Challenge DNA Vaccine Expressing Tat
A V Karasev*‡1, S Foulke2, C Wellens1, I Zwierzynski1, R Baldwin1, 
H Koprowski1 and MS Reitz Jr2
Address: 1Biotechnology Foundation Laboratories at Thomas Jefferson University, Department of Microbiology and Immunology, Doylestown, 
PA 18901 and 2Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, MD 21202
Email: A V Karasev* - alexander.karasev@jefferson.edu
* Corresponding author    ‡Presenting author    
The Tat protein has been recently explored as a prospec-
tive vaccine candidate against HIV-1 with broad, subtype
non-specific action. A truncated version of Tat()Tat) with
the basic loop, involved in immunosuppression, removed
has been previously demonstrated as efficacious as the
full-size Tat protein. We produced both full-size Tat and
truncated _Tat in plants, including one edible species –
spinach, thus simultaneously addressing problems of an
inexpensive Tat production and a direct delivery through
the mucosal route. We tested this oral delivery route in a
mouse model. Tat and )Tat genes were assembled from a
set of synthetic overlapping oligonucleotides, and subse-
quently cloned into a plant virus-based expression vector.
Codon optimization allows production of up to 300–500
mg of Tat or )Tat antigen per 1 g of leaf tissue in spinach.
Spinach plants inoculated with the Tat-producing con-
structs were collected and fed to mice 7–14 days post inoc-
ulation with or without mucosal adjuvants. Mice were fed
with the Tat-producing or control vector-inoculated spin-
ach. After 3 voluntary feedings, 1 week apart, 1 g per mice,
no differences were detected in the growth rate or behav-
ior of the animals fed with these two types of spinach.
None of the animals developed measurable Tat antibod-
ies. Challenge DNA vaccination with a homologous Tat-
expressing construct was performed using a gene gun. Fol-
lowing DNA vaccination, however, mice previously
receiving oral Tat with cholera toxin as an adjuvant, devel-
oped higher antibody titers to Tat than did the controls,
with the titers peaking at four weeks post-vaccination.
Thus, our data suggested that oral Tat primed for the
development of Tat antibodies when mice were challenge-
vaccinated with plasmid DNA for expression of Tat.
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